2016
DOI: 10.1155/2016/2150763
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?

Abstract: Coronary artery disease (CAD) and its complication remain the leading cause of mortality in industrialized countries despite great advances in terms of diagnosis, prognosis, and treatment options. MicroRNAs (miRNAs), small noncoding RNAs, act as posttranscriptional gene expression modulators and have been implicated as key regulators in several physiological and pathological processes linked to CAD. Circulating miRNAs have been evaluated as promising novel biomarkers of CAD, acute coronary syndromes, and acute… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 41 publications
(30 citation statements)
references
References 66 publications
0
30
0
Order By: Relevance
“…Several avenues for research are worth exploring. For instance, translational studies on the precise cellular mechanisms involved in EVC toxicity are needed, exploring for instance microRNA, inflammatory cascade, autophagy, apoptosis, and regeneration [36][37][38]. Observational studies on large samples are needed to accurately gauge the short and long-term risks of EVC in apparently healthy subjects and in patients with cardiovascular disease [39].…”
Section: Discussionmentioning
confidence: 99%
“…Several avenues for research are worth exploring. For instance, translational studies on the precise cellular mechanisms involved in EVC toxicity are needed, exploring for instance microRNA, inflammatory cascade, autophagy, apoptosis, and regeneration [36][37][38]. Observational studies on large samples are needed to accurately gauge the short and long-term risks of EVC in apparently healthy subjects and in patients with cardiovascular disease [39].…”
Section: Discussionmentioning
confidence: 99%
“…Fifty-four healthy participants of similar age group, who were attendants of the patients and were clinically unsuspected as they had no signs or symptoms of CAD, were enrolled in this study as control subjects. Based on earlier literature available on similar types of studies [14,16,17,20,22,25,26], we arrived at a decision of having an appropriate study size of about 70-80 each of cases and control. Now in order to get about 70 proven CAD cases, approximately 100 angiography cases had to be included.…”
Section: Study Subjectsmentioning
confidence: 99%
“…Several studies impart information establishing miRNAs as key regulators of cardiovascular diseases [14,15]. Interestingly, few reports have proposed the diagnostic potential of miRNAs in cardiac complications such as MI [16] and heart failure [17].…”
Section: Introductionmentioning
confidence: 99%
“…In fact, ncRNA dysregulations are associated with cardiovascular and metabolic diseases [ 198 , 199 ]. Circulating miRNAs such as miR-126, miR-17, miR-145, and miR-222 are currently considered indicators of cardiovascular risk [ 200 ], as their levels in body fluids or plasma reflect the evolution of cardiovascular disorders, including myocardial infarction, heart failure, diabetes mellitus, stroke, and acute pulmonary embolism [ 201 , 202 ]. Some miRNAs could also possess prognostic value.…”
Section: Antioxidant Approach By Natural Agents: the Road To Detecmentioning
confidence: 99%